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Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway and systemic inflammation that is associated with an increased risk of cardiovascular disease (CVD) independent of other traditional risk factors (Sin et al. 2005) . This enhanced pro-inflammatory milieu provides the necessary environment for the development and progression of atherosclerosis and has been linked to endothelial dysfunction (Barr et al. 2007; Eickhoff et al. 2008; Moro et al. 2008) , arterial stiffening (Sabit et al. 2007 ) and carotid intima-media thickening (cIMT; Kim et al. 2011) in COPD. These adverse structural and functional changes to the vasculature occur early in the atherosclerotic process and are predictive of future cardiovascular events (Inaba et al. 2010; Vlachopoulos et al. 2010) .
Aerobic exercise is a potent systemic therapy known to protect against the development and progression of CVD. In addition to its anti-inflammatory benefits, studies have shown that regular aerobic exercise attenuates age-related reductions in arterial stiffness (Tanaka et al. 2000) and improves vascular function in sedentary ageing (Suboc et al. 2014; Grace et al. 2015) and in chronic disease (Hambrecht et al. 2003) . To date, few studies have investigated whether exercise training directly improves vascular function in individuals with COPD (Vivodtzev et al. 2010; Gale et al. 2011; Vanfleteren et al. 2014) . These initial studies have focused only on indices of arterial stiffness and report conflicting results. As such, further studies are required to comprehensively examine whether exercise can beneficially alter the vasculature in individuals with COPD.
It is well established that the benefits of exercise training are multifactorial in COPD (Troosters et al. 2005) ; however, the degree of exercise-induced adaptations is highly varied because many factors can influence the physiological benefits of aerobic exercise. Periodized exercise training uses systematically planned varying levels of intensity and duration to fluctuate the training stimulus (Sasso et al. 2015) and has been shown to be superior to generic training programmes for optimizing physiological adaptations and performance in both athletic and chronic disease populations (Klijn et al. 2013; Sasso et al. 2015) . However, no study has determined the effects of periodized aerobic training on vascular adaptations in COPD. The aim of this study was to examine the effects of periodized aerobic training on measures of vascular structure and function and systemic inflammation in patients with COPD. Additionally, no previous study has investigated the effect of periodized aerobic training on vascular function in older adults; as such, we included a healthy control group to determine whether the vasculature adapts in a similar fashion in individuals with COPD compared with healthy ageing. It was primarily hypothesized that aerobic training would improve endothelial function as measured by brachial artery flow-mediated dilatation (FMD) in patients with COPD. It was also hypothesized that measures of arterial stiffness, cIMT and systemic inflammation would improve after training in patients with COPD and healthy control subjects, and that control subjects would have greater improvements in vascular structure and function than COPD patients.
Methods

Participants and study design
Stable patients (>3 months exacerbation free) with COPD (forced expiratory volume in 1 second (FEV 1 ) / forced vital capacity (FVC) < 0.7 and below the lower limit of normal, and >10 pack year smoking history) were recruited from pulmonary function laboratories and a database of patients who had previously undertaken pulmonary rehabilitation. Healthy control subjects matched for sex, body mass index, age (within 5 years) and activity were recruited from the local community. To avoid enhancing between-group differences by using active control subjects, physical activity levels were matched on weekly leisure activity scores (Godin & Shephard, 1985) . Participants were excluded if they were: <40 years old, body mass index ࣙ 35 kg m −2 , currently smoking (quit <6 months), on supplemental oxygen, had diabetes or another respiratory disorder(s), presented with cardiovascular contraindications (i.e. ECG indicative of ischaemia, complex ectopy), orthopaedic limitations to exercise, had a previous history of major cardiovascular disease (i.e. myocardial infarction, stroke, heart failure), uncontrolled hypertension, or currently performing structured exercise. Control subjects were also excluded if they had a >10 pack-year smoking history. This study received institutional clinical research ethics board approval (H11-02770) and was registered at ClinicalTrials.gov (NCT02875522). All participants signed an informed consent that conformed to the standards of the Declaration of Helsinki, and both groups performed identical assessments.
On day 1, a pulmonary function test and a cycling incremental cardiopulmonary exercise test (CPET) with expired gas analysis (Vmax 29C; SensorMedics, Yorba Linda, CA, USA) were performed according to American Thoracic Society recommendations (American Thoracic Society and American College of Chest Physicians, 2003) . After >12 h fasting, day 2 consisted of a comprehensive vascular assessment and a venous blood sample. Participants then performed 8 weeks of aerobic exercise training before repeating baseline assessments. Prescription medications were not withheld during testing days or training sessions, and medication dose was constant during the study.
Comprehensive vascular assessment
Arterial stiffness and cIMT. Local and regional arterial stiffness was measured as previously described (Koelwyn et al. 2012) . Central and peripheral pulse wave velocity (PWV) were assessed using a hand-held tonometer (SPT-301; Millar Instruments, Houston, TX, USA), and carotid artery compliance, distensibility and β-stiffness index were measured using concurrent tonometry and B-mode ultrasound (T3000L; Terason, Burlington, MA, USA) with continuous blood pressure (BP) measurement (Finapres Medical Systems, Biomedical Instruments Amsterdam, The Netherlands). Carotid intima-media thickness was measured in the left carotid artery (Vivid-q; GE, Fairfield, CT, USA) with concurrent ECG gating. The IMT at end diastole of 10 beats was obtained and averaged in the anterior, lateral and medial planes and reported as the mean cIMT.
Vascular reactivity. All measures were performed according to the recommendations of Thijssen et al. (2011) . In brief, a 10 MHz multifrequency linear array ultrasound probe was positioned above the antecubital fossa of the right brachial artery, proximal to a pneumatic cuff, which was inflated to ß220 mmHg for 5 min to induce FMD. Brachial artery diameter, blood flow and shear stress were measured with concurrent acquisition of high-resolution B-mode and pulse wave Doppler velocity signal (T3000L; Terason, Burlington, MA, USA) for 1 min at baseline, 30 s before and 3 min after cuff deflation. Antegrade shear, retrograde shear and the sum of shear were calculated from resting baseline measurements. Shear rate area under the curve was calculated from the point of cuff deflation until the time of peak dilatation. Flow-mediated dilatation corrected for baseline brachial diameter was assessed according to Atkinson & Batterham (2013) . The same experienced technician with a standard error of measurement of 0.03% and a coefficient of variation of 3.6% performed all FMD measurements. After 30 min of rest, endothelium-independent dilatation was assessed by measuring brachial artery diameter and blood flow for 1 min at rest and 10 min following a 400 μg sublingual dose of nitroglycerin. Ultrasound images were analysed by a trained individual blinded to both group and study time point using custom-designed edge-detection software independent of investigator bias, which has a coefficient of variation of 6.7-10.9% (Woodman et al. 2001) .
Markers of CVD risk and systemic inflammation.
Complete blood cell count, lipid profile and C-reactive protein were measured from a venous sample. Additional samples were centrifuged for analysis of systemic inflammation [interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-α (TNF-α)], an anti-inflammatory biomarker [interleukin-10 (IL-10)] and other biomarkers of cardiovascular risk [intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and matrix metallopeptidase-9 (MMP-9)]. Analysis was performed using Luminex multiplex bead-based technology (Applied Cytometry Systems, Sheffield, UK) as previously described (Davidson et al. 2012) .
Aerobic exercise training
An exercise physiologist supervised all sessions. Exercise training was performed on upper and lower body cycle ergometers three times per week for 8 weeks because 24 sessions is the typical length of a pulmonary rehabilitation programme within North America (Desveaux et al. 2015) . The exercise prescription was periodized to undulate the daily training stress throughout 8 weeks (non-linear periodization), with an aim to increase shear stress, a key regulator of vascular adaptations to exercise (Tinken et al. 2010) . While lower body cycling increases brachial blood flow and thus shear rate by ß2.5-fold , we also incorporated arm crank ergometry to enhance blood flow directly through the brachial arteries (Tinken et al. 2010) . For lower body cycling, the initial intensity was 50% peak workload (W max ; Eves et al. 2009 ). Weeks 1-4 focused on increasing aerobic capacity and shear stress by fluctuating training at moderate intensities (50-75%W max ), while gradually increasing the total duration from 20 to 45 min. In weeks 5-8, sessions were stratified into hard, moderate and moderate-hard training days, while the weekly training volume continued to increase (Fig. 1) . The hard session consisted of intervals at 80-95%W max for 3 min, with 3 min recovery at 40-45%W max , for five or six intervals. The moderate session was performed at 50-80%W max for 40-45 min, and the moderate-hard session consisted of 55-85%W max for 35-45 min. Arm cranking started at 10 W for 10 min; once 20 min was achieved without stopping, the intensity was progressed. Intensity progressed for upper and lower cycling if the previous session was completed without stopping at a Borg dyspnoea rating ࣘ3 (Borg, 1982) . Missed sessions could be made up, and participants were allowed to continue performing physical activity, but were discouraged from participating in other forms of structured exercise.
Statistical analysis and sample size calculation
The primary outcome was the change in FMD in patients with COPD. Secondary outcomes included changes in arterial stiffness, cIMT, endothelium-independent 
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dilatation and inflammatory mediators in COPD patients and compared with control subjects. Intention-to-treat analysis was used for primary and secondary outcomes, with last observation carried forward for participants lost to follow-up. All statistical calculations were made using Statistica, v.10 (Statsoft, Tulsa, OK, USA), with an α = 0.05. Student's paired and unpaired t tests were performed for parametric data. Non-parametric data were evaluated using Mann-Whitney rank sum or Wilcoxon signed-ranks tests. ANOVA was performed as a secondary analysis to assess time and group interactions. Pearson's or Spearman's correlations were performed to examine relationships between changes in vascular structure and function, exercise training measures and other outcomes. This preliminary trial was designed specifically to assess the efficacy of periodized aerobic training for improving vascular function in patients with COPD and to generate data to power a larger prospective randomized controlled trial. However, with 22 patients, an α = 0.05, a β = 0.8 and an SD of the change in FMD of 1.6% (generated from pilot data), we were powered to detect a minimally clinically important change in FMD of 1% .
Results
Participants
Twenty-four COPD patients participated in training, and 22 completed the intervention (Fig. 1) . No serious adverse events occurred during testing or training. Two patients did not complete the intervention because of significant arrhythmias during training that did not present during the CPET and were sent for further cardiovascular investigation. Twenty sedentary control subjects were recruited and completed training. The exercise prescription performed is presented in Fig. 2 . Adherence to the exercise training was 91 and 97%, and adherence to the specific exercise prescription for a given session was 82 and 99% in the COPD and control groups, respectively. Participant characteristics and pulmonary function test results are presented in Table 1 . Based on guidelines for the assessment of CVD risk (Goff et al. 2014) 90, 10 and 0% of patients with COPD ranked in the high, moderate and low CVD risk categories, whereas in the control subjects 45, 10 and 45% ranked in the respective categories.
Vascular function and structure
Exercise training had no significant effect on FMD (Fig. 3) , endothelium-independent dilatation or any shear stress measures in either group (Table 2) . Flow mediated dilation corrected for baseline diameter was also unchanged in COPD (4.7 ± 1.9% vs. 4.8 ± 2.0%, p = 0.78) and controls (4.3 ± 2.3% vs. 4.6 ± 2.2%, p = 0.66), from pre to post training respectively. There were no significant differences at baseline, post-training or between change scores for any FMD or nitroglycerin variables when comparing COPD patients with control subjects (Fig. 3 and Table 2 ). There The relative training intensity for each session is depicted by the grey bars. Although the absolute intensities varied, all participants performed each session at the same relative intensity. Total training volume for the COPD patients (circles) and control subjects (triangles) was calculated as power (W) × duration for each subject, and then averaged across groups. Data are presented as means ± SD. were no significant changes in any measures of arterial stiffness (Fig. 4 and Table 2 ) after training in either group or at any time point when comparing groups. Carotid diastolic blood pressure (DBP) was significantly reduced in COPD patients, and carotid systolic blood pressure (SBP) and DBP were significantly reduced in control subjects.
Resting peripheral SBP, DBP and mean arterial pressure (MAP) were also reduced in both groups (Table 2) .
Haematological and cardiorespiratory responses
Only IL-8 and IL-6 were significantly reduced in the COPD and control group, respectively (Table 3) . Lipid profiles and complete blood cell counts did not change significantly in either group. Aerobic training significantly improved absolute and relative peak aerobic power (V O 2 peak ), W max , O 2 pulse and leg fatigue in both groups, while dyspnoea was reduced only in COPD patients (Table 4) . At baseline,V O 2 peak and W max were significantly higher in control subjects, and the change inV O 2 peak , W max , O 2 pulse and the total training volume achieved after training were significantly greater in the control group. Body mass did not change after training in either group.
Correlates of change in FMD
In COPD, there were no significant correlations between the change in FMD and baseline FMD or FEV 1 %pred. A significant relationship was found between the change in FMD and change in IL-6 (r 2 = 0.25, P = 0.02), TNF-α (r 2 = 0.25, P = 0.02) and retrograde shear rate (r 2 = 0.26, P = 0.01). In the control subjects, the change in FMD was significantly related to baseline FMD (r 2 = 0.48, P = < 0.01) and the change in VCAM-1 (r 2 = 0.30, P = 0.01). The change in FMD was not significantly related J. C. Gelinas and others to other markers of vascular structure or function,V O 2 peak or training volume in either group.
Discussion
The new finding of this study was that FMD was not altered after 8 weeks of periodized aerobic exercise training in COPD patients or control subjects. There were also no significant changes in secondary outcomes in either group despite improvements inV O 2 peak , blood pressure and dyspnoea.
Vascular reactivity in COPD
A number of previous studies have reported improvements in vascular function after an aerobic exercise intervention in health and disease (Hambrecht et al. 2003; Suboc et al. 2014; Grace et al. 2015) . However, the lack of improvement in FMD in our COPD cohort is in agreement with a number of studies in other chronic disease populations (Kitzman et al. 2013; Van Craenenbroeck et al. 2015 ). These findings demonstrate that even well-designed exercise programmes may not elicit an improvement in brachial endothelial function in some clinical populations.
Chronic aerobic exercise increases arterial diameter because of outward remodelling of the vascular wall in response to the continuous increase in shear stress associated with increased cardiac output (Tinken et al. 2010) . Thus, FMD may not increase after exercise training because the larger vessel diameter eventually normalizes endothelial shear stress (Tinken et al. 2010) . However, in the present study baseline and peak diameters did not change after training, indicating that no compensatory structural adaptations occurred. As patients with COPD commonly exercise at relatively low absolute intensities and thus cardiac outputs (Oelberg et al. 1998) owing to deconditioning and dyspnoea, it is possible that patients were unable to generate adequate shear stress to enhance endothelial function and/or structural changes with this short-duration programme.
Vascular structure in COPD
Contrary to our secondary hypothesis, local and regional arterial stiffness did not improve after training in COPD patients. In two previous studies, a 4 week cycling training programme (Vivodtzev et al. 2010 ) and a 7 week outpatient pulmonary rehabilitation programme (including aerobic and strength training; Gale et al. 2011) improved peripheral and central PWV, respectively. In contrast, a third study, by Vanfleteren et al. (2014) , reported no change in central PWV in 129 patients with COPD after 40 sessions of pulmonary rehabilitation. Discrepancies between studies may be attributable to methodological differences; however, considering that our study used multiple measures of local and regional arterial stiffness, in combination with the findings of Vanfleteren et al. (2014) , it would appear that relatively short-term exercise programmes may not systematically reduce arterial stiffness in COPD.
The relatively low absolute volume/intensity of exercise in COPD may be inadequate to modify the fragmentation of elastin fibres and calcium deposits that have occurred over years (Lakatta & Levy, 2003) , resulting in little or no change in arterial stiffness and cIMT. Additionally, if the cross-sectional area of a vessel does not increase, compliance and distensibility will increase only in the presence of a reduction in pulse pressure (Koelwyn et al. 2012) . Neither carotid diameter or pulse pressure was reduced in this study, which supports the lack of observed reductions in local arterial stiffness despite reductions in carotid DBP and peripheral BP. As such, although small changes in vascular tone might have occurred, they appear independent of compositional changes in vascular structure. 
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Central PWV is a well-accepted independent indicator of CVD outcome (Vlachopoulos et al. 2010) , and the inability to reduce central PWV or other compliance or stiffness measures suggests that 8 weeks of aerobic training might not confer much CVD risk reduction. However, even a 5 mmHg reduction in SBP, and 2 mmHg reduction in DBP, has been shown to reduce the risk of cardiovascular death, myocardial infarction or stroke by ß12% (Verdecchia et al. 2010) . Considering that SBP and DBP were reduced by 6 and 5 mmHg, respectively, in our study, it appears that the CVD risk of patients was reduced independent of changes in FMD or central PWV.
Between-group comparisons
Vascular reactivity or arterial stiffness did not differ at baseline or after exercise training in COPD patients compared with control subjects. These findings support one previous study that demonstrated no differences in endothelial function between COPD patients and control subjects when assessed by venous occlusion plethysmography (Maclay et al. 2009) . By specifically recruiting a sedentary control group to account for the known effects of chronic physical activity/exercise on vascular function, our findings suggest that endothelial function in our COPD cohort was similar to sedentary ageing and not attributable to dysfunction associated with the disease itself. The inflammatory and blood lipid profiles were similar between our groups, which might help to explain the lack of vascular adaptations in either group after training. However, this probably does not entirely explain why our intervention has no vascular effect in our control subjects, unlike previous studies (Suboc et al. 2014; Grace et al. 2015) .
A significant improvement inV O 2 peak , blood pressure and exertional symptoms occurred in both groups, demonstrating the effectiveness of our programme for eliciting clinically important physiological adaptations. To date, only one previous study has examined the effect of a periodized aerobic and strength training programme in COPD and reported greater improvements in cycle endurance time and health-related quality of life with periodized training compared with a more traditional programme (Klijn et al. 2013 ). Although we also used periodized training in a non-linear approach, our primary outcome was the change in FMD and, as such, our exercise (C) . D, mean change in peripheral PWV in control subjects (n = 20) and COPD patients (n = 24). E and F, individual changes in peripheral PWV in control subects (E) and COPD patients (F). prescription was different from that in the aforementioned study. It is interesting to note that our control group had a significantly greater improvement inV O 2 peak , W max and O 2 pulse than our COPD group performing the same relative exercise intensities and durations. This implies that COPD may attenuate the adaptive responses to aerobic training or that patients may not be able to perform the absolute dose of exercise needed to achieve similar adaptations compared with healthy ageing. However, considering thaṫ V O 2 peak is one of the strongest predictors of cardiovascular morbidity and mortality (Myers et al. 2002) , this finding again supports that our intervention improved the CVD risk in this cohort.
Correlates of FMD in COPD
Despite no significant change in systemic inflammation in COPD (except IL-8), a significant relationship was found between the improvement in FMD and the reduction in IL-6 and TNF-α, suggesting that reductions in systemic inflammation might be needed for improvements in endothelial function. Additionally, changes in blood flow patterns can influence vascular function, because increased retrograde shear stress has been associated with endothelial dysfunction (Schreuder et al. 2014) . In our COPD group, an increase in FMD was associated with a reduction in retrograde shear. However, as this was a relatively modest correlation, further research is warranted to investigate the importance of alterations in blood flow patterns on endothelial function in COPD.
Limitations
A number of limitations within this study should be acknowledged. First, as the study was designed to help power a prospective randomized controlled trial, a limitation is the relatively small sample size. However, using the change in FMD observed, 1784 patients would be needed to achieve statistical significance, and the effect would be unlikely to be clinically relevant . Second, despite significantly reducing peripheral blood pressure, reductions in vascular sympathetic activation might not have been great enough to alter vascular function in our cohort; however, this effect remains speculative. Third, although we did not exclude patients on vasoactive medications that might influence vascular adaptations, vascular function has been shown to improve after exercise training despite cardiovascular medication use in other CVD populations (Hambrecht et al. 2003) . Fourth, the duration and/or frequency of training might play a larger role in facilitating vascular adaptations in COPD, and 24 sessions might not be sufficient. Whether alternative prescriptions, periodization models or doses of exercise are able to J. C. Gelinas and others 
Conclusion
A periodized aerobic training programme similar in length to many typical pulmonary rehabilitation programmes does not improve vascular structure and function in patients with COPD. However, the improvements iṅ V O 2 peak and blood pressure after training support that CVD risk is reduced independent of changes in markers of vascular health.
